The Association of Public and Land-grant Universities (APLU) hosted its four-day annual winter meeting the week of November 12 in Washington, DC. Stony Brook University President Samuel L. Stanley Jr., MD served on two panels, “Back Tracking the American Dream?” and “The Next Frontier in University Technology Transfer: Evolving into a More Responsive and Engaged Enterprise.”
On November 14, APLU and the Association of American Universities (AAU) hosted the inaugural University Innovation and Entrepreneurship Showcase on Capitol Hill, spotlighting 22 startup companies that have created products born out of federally funded, university-based research. The national associations received about 100 highly competitive applications from more than 40 institutions across the country to participate in the prestigious showcase. Stony Brook University’s Traverse Biosciences was selected. Traverse Biosciences is commercializing novel drug candidates for the treatment of inflammatory diseases and related conditions affecting humans and companion animals.
“Traverse Biosciences is a prime example of how a relatively modest investment by the federal government can help leverage the unparalleled infrastructure and intellectual capacity of America’s major research institutions to create commercially promising technologies with the potential to impact health and society, while simultaneously stimulating economic growth,” said President Stanley. “The University Innovation and Entrepreneurship Showcase highlights both the impact and the importance of continued investment in discovery research to fuel technology development, entrepreneurship and commercialization, as well as to maintain the global competitiveness of our nation.”
“It is an honor to represent Stony Brook University at the inaugural University Innovation and Entrepreneurship Showcase, where we also have a unique opportunity to advocate for continued federal funding for basic and applied research that will undoubtedly lead to commercially promising technologies meant to impact health and society,” said Joseph Scaduto, Founder and CEO of Traverse Biosciences.
Mr. Scaduto added, “The economic prosperity and global competitiveness of our nation will certainly depend on the robust and ongoing investment in innovation that will spawn the next generation of high-technology industries and create the jobs of the future.”